Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:36
05/23/23
05/23
09:36
05/23/23
09:36
ZM

Zoom Video

$71.44 /

+2.075 (+2.99%)

, CVX

Chevron

$152.43 /

-2.81 (-1.81%)

, MYGN

Myriad Genetics

$20.05 /

+0.71 (+3.67%)

, QTRX

Quanterix

$19.22 /

+0.365 (+1.94%)

, CCCS

CCC Intelligent Solutions

$9.93 /

+0.075 (+0.76%)

, ICPT

Intercept

$9.52 /

-4.03 (-29.74%)

, RAIN

Rain Oncology

$1.20 /

-8.72 (-87.90%)

, IART

Integra LifeSciences

$50.73 /

+0.93 (+1.87%)

, MRVI

Maravai Lifesciences

$13.60 /

+0.195 (+1.46%)

, WPM

Wheaton Precious Metals

$47.81 /

-0.25 (-0.52%)

, STLD

Steel Dynamics

$97.16 /

+0.09 (+0.09%)

, NUE

Nucor

$139.87 /

+1.18 (+0.85%)

, CLF

Cleveland-Cliffs

$14.87 /

-0.06 (-0.40%)

, FIVN

Five9

$63.92 /

+2.4 (+3.90%)

, AXNX

Axonics

$51.58 /

+1.24 (+2.46%)

The most talked about and…

ShowHide Related Items >><<
ZM Zoom Video
$71.44 /

+2.075 (+2.99%)

WPM Wheaton Precious Metals
$47.81 /

-0.25 (-0.52%)

STLD Steel Dynamics
$97.16 /

+0.09 (+0.09%)

RAIN Rain Oncology
$1.20 /

-8.72 (-87.90%)

QTRX Quanterix
$19.22 /

+0.365 (+1.94%)

NUE Nucor
$139.87 /

+1.18 (+0.85%)

MYGN Myriad Genetics
$20.05 /

+0.71 (+3.67%)

MRVI Maravai Lifesciences
$13.60 /

+0.195 (+1.46%)

ICPT Intercept
$9.52 /

-4.03 (-29.74%)

IART Integra LifeSciences
$50.73 /

+0.93 (+1.87%)

FIVN Five9
$63.92 /

+2.4 (+3.90%)

CVX Chevron
$152.43 /

-2.81 (-1.81%)

CLF Cleveland-Cliffs
$14.87 /

-0.06 (-0.40%)

CCCS CCC Intelligent Solutions
$9.93 /

+0.075 (+0.76%)

AXNX Axonics
$51.58 /

+1.24 (+2.46%)

ZM Zoom Video
$71.44 /

+2.075 (+2.99%)

05/23/23 Piper Sandler
Zoom Video price target lowered to $76 from $78 at Piper Sandler
05/23/23 Evercore ISI
Zoom Video price target lowered to $75 from $85 at Evercore ISI
05/23/23 Needham
Needham stay neutral on Zoom Video pending more visibility on Enterprise growth
05/23/23 RBC Capital
Zoom Video Online segment stabilizing but Enterprize slowing, says RBC Capital
CVX Chevron
$152.43 /

-2.81 (-1.81%)

05/23/23 Morgan Stanley
Chevron price target raised to $198 from $192 at Morgan Stanley
05/23/23 HSBC
Chevron upgraded to Buy from Hold at HSBC
05/22/23 KeyBanc
KeyBanc expects PDC to trade up toward $70/share after 'surprising' Chevron deal
05/19/23 Mizuho
Chevron price target lowered to $196 from $206 at Mizuho
MYGN Myriad Genetics
$20.05 /

+0.71 (+3.67%)

05/23/23 Goldman Sachs
Myriad Genetics upgraded to Buy from Sell at Goldman Sachs
03/06/23 Stephens
Myriad Genetics price target raised to $24 from $17 at Stephens
01/18/23 Raymond James
Myriad Genetics upgraded to Outperform from Market Perform at Raymond James
01/18/23 Raymond James
Myriad Genetics upgraded to Outperform from Market Perform at Raymond James
QTRX Quanterix
$19.22 /

+0.365 (+1.94%)

05/23/23 Goldman Sachs
Quanterix upgraded to Buy from Neutral at Goldman Sachs
05/15/23 Canaccord
Quanterix price target raised to $19 from $13 at Canaccord
08/15/22 Canaccord
Quanterix downgraded to Hold from Buy at Canaccord
08/09/22 TD Cowen
Quanterix downgraded to Market Perform from Outperform at Cowen
CCCS CCC Intelligent Solutions
$9.93 /

+0.075 (+0.76%)

05/23/23 Evercore ISI
Evercore upgrades 'under the radar' CCC Intelligent Solutions to Outperform
05/23/23 Evercore ISI
CCC Intelligent Solutions upgraded to Outperform from In Line at Evercore ISI
04/25/23 Jefferies
CCC Intelligent Solutions assumed with a Buy at Jefferies
04/13/23 JPMorgan
CCC Intelligent Solutions initiated with an Overweight at JPMorgan
ICPT Intercept
$9.52 /

-4.03 (-29.74%)

05/23/23 BofA
Intercept price target lowered to $14 from $17 at BofA
05/23/23 Canaccord
Intercept price target lowered to $12 from $26 at Canaccord
05/23/23 Needham
Needham downgrades Intercept, says NASH approval 'highly unlikely'
05/23/23 Needham
Intercept downgraded to Hold from Buy at Needham
RAIN Rain Oncology
$1.20 /

-8.72 (-87.90%)

05/23/23 H.C. Wainwright
Rain Oncology downgraded to Neutral from Buy at H.C. Wainwright
05/23/23 Oppenheimer
Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer
05/23/23 Citi
Rain Oncology downgraded to Neutral from Buy at Citi
05/22/23 Oppenheimer
Rain Oncology downgraded to Perform from Outperform at Oppenheimer
IART Integra LifeSciences
$50.73 /

+0.93 (+1.87%)

05/23/23 Citi
Citi downgrades Integra to Sell, sees further guidance cuts
05/23/23 Citi
Integra LifeSciences downgraded to Sell from Neutral at Citi
05/18/23 Truist
Integra LifeSciences price target lowered to $54 from $58 at Truist
04/27/23 JMP Securities
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities
MRVI Maravai Lifesciences
$13.60 /

+0.195 (+1.46%)

05/23/23 Credit Suisse
Maravai Lifesciences downgraded to Neutral from Outperform at Credit Suisse
05/09/23 Deutsche Bank
Maravai Lifesciences price target lowered to $23 from $25 at Deutsche Bank
05/09/23 Goldman Sachs
Maravai Lifesciences downgraded to Neutral at Goldman after guidance cut
05/09/23 Goldman Sachs
Maravai Lifesciences downgraded to Neutral from Buy at Goldman Sachs
WPM Wheaton Precious Metals
$47.81 /

-0.25 (-0.52%)

05/23/23 RBC Capital
Wheaton Precious Metals cut to Sector Perform at RBC Capital on valuation
05/23/23 RBC Capital
Wheaton Precious Metals downgraded to Sector Perform from Outperform at RBC Capital
05/08/23 National Bank
Wheaton Precious Metals price target raised to C$80 at National Bank
04/21/23 Barclays
Wheaton Precious Metals price target raised to $43 from $42 at Barclays
STLD Steel Dynamics
$97.16 /

+0.09 (+0.09%)

05/23/23 JPMorgan
Steel Dynamics initiated with an Underweight at JPMorgan
05/05/23 UBS
Steel Dynamics price target lowered to $100 from $110 at UBS
04/21/23 Credit Suisse
Steel Dynamics price target raised to $115 from $106 at Credit Suisse
04/05/23 BofA
Steel Dynamics downgraded to Neutral from Buy at BofA
NUE Nucor
$139.87 /

+1.18 (+0.85%)

05/23/23 JPMorgan
Nucor initiated with an Underweight at JPMorgan
05/05/23 UBS
Nucor price target lowered to $140 from $145 at UBS
03/17/23 Credit Suisse
Nucor price target raised to $156 from $140 at Credit Suisse
03/15/23 Citi
Steel Dynamics downgraded to Neutral from Buy at Citi
CLF Cleveland-Cliffs
$14.87 /

-0.06 (-0.40%)

05/23/23 JPMorgan
Cleveland-Cliffs initiated with a Neutral at JPMorgan
03/20/23 Wolfe Research
Cleveland-Cliffs upgraded to Peer Perform from Underperform at Wolfe Research
02/15/23 B. Riley
Cleveland-Cliffs price target lowered to $26 from $27 at B. Riley
01/31/23 B. Riley
Cleveland-Cliffs Q4 likely to represent trough earnings, says B. Riley
FIVN Five9
$63.92 /

+2.4 (+3.90%)

05/23/23 Roth MKM
Five9 resumed with a Buy at Roth MKM
05/05/23 Canaccord
Five9 price target lowered to $80 from $90 at Canaccord
03/23/23 Rosenblatt
Five9 initiated with a Buy at Rosenblatt
02/23/23 Deutsche Bank
Five9 price target raised to $70 from $55 at Deutsche Bank
AXNX Axonics
$51.58 /

+1.24 (+2.46%)

05/23/23 CL King
Axonics initiated with Buy on 'underpenetrated markets' at CL King
05/23/23 CL King
Axonics initiated with a Buy at CL King
05/02/23 Needham
Axonics price target raised to $73 from $71 at Needham
04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
ZM Zoom Video
$71.44 /

+2.075 (+2.99%)

WPM Wheaton Precious Metals
$47.81 /

-0.25 (-0.52%)

STLD Steel Dynamics
$97.16 /

+0.09 (+0.09%)

RAIN Rain Oncology
$1.20 /

-8.72 (-87.90%)

QTRX Quanterix
$19.22 /

+0.365 (+1.94%)

NUE Nucor
$139.87 /

+1.18 (+0.85%)

MYGN Myriad Genetics
$20.05 /

+0.71 (+3.67%)

MRVI Maravai Lifesciences
$13.60 /

+0.195 (+1.46%)

ICPT Intercept
$9.52 /

-4.03 (-29.74%)

IART Integra LifeSciences
$50.73 /

+0.93 (+1.87%)

FIVN Five9
$63.92 /

+2.4 (+3.90%)

CVX Chevron
$152.43 /

-2.81 (-1.81%)

CLF Cleveland-Cliffs
$14.87 /

-0.06 (-0.40%)

CCCS CCC Intelligent Solutions
$9.93 /

+0.075 (+0.76%)

AXNX Axonics
$51.58 /

+1.24 (+2.46%)

  • 03
    Aug
ZM Zoom Video
$71.44 /

+2.075 (+2.99%)

STLD Steel Dynamics
$97.16 /

+0.09 (+0.09%)

QTRX Quanterix
$19.22 /

+0.365 (+1.94%)

MRVI Maravai Lifesciences
$13.60 /

+0.195 (+1.46%)

CVX Chevron
$152.43 /

-2.81 (-1.81%)

ZM Zoom Video
$71.44 /

+2.075 (+2.99%)

WPM Wheaton Precious Metals
$47.81 /

-0.25 (-0.52%)

STLD Steel Dynamics
$97.16 /

+0.09 (+0.09%)

NUE Nucor
$139.87 /

+1.18 (+0.85%)

ICPT Intercept
$9.52 /

-4.03 (-29.74%)

FIVN Five9
$63.92 /

+2.4 (+3.90%)

CVX Chevron
$152.43 /

-2.81 (-1.81%)

CLF Cleveland-Cliffs
$14.87 /

-0.06 (-0.40%)

AXNX Axonics
$51.58 /

+1.24 (+2.46%)

ZM Zoom Video
$71.44 /

+2.075 (+2.99%)

WPM Wheaton Precious Metals
$47.81 /

-0.25 (-0.52%)

STLD Steel Dynamics
$97.16 /

+0.09 (+0.09%)

NUE Nucor
$139.87 /

+1.18 (+0.85%)

CVX Chevron
$152.43 /

-2.81 (-1.81%)

CLF Cleveland-Cliffs
$14.87 /

-0.06 (-0.40%)

Initiation
Axonics initiated with Buy on 'underpenetrated markets' at CL King » 09:07
05/23/23
05/23
09:07
05/23/23
09:07
AXNX

Axonics

$51.58 /

+1.24 (+2.46%)

CL King analyst Kristen…

CL King analyst Kristen Stewart initiated coverage of Axonics with a Buy rating and $75 price target. Axonics competes in "large, underpenetrated markets, with market-leading technology, and has strong management and sales execution to capitalize on the market opportunity," the analyst tells investors in a research note. The firm says the company's products are used to treat overactive bladder, fecal incontinence, non-obstructive urinary retention and female stress urinary incontinence, which are large and underpenetrated market opportunities. King sees upside potential in the stock.

ShowHide Related Items >><<
AXNX Axonics
$51.58 /

+1.24 (+2.46%)

AXNX Axonics
$51.58 /

+1.24 (+2.46%)

05/23/23 CL King
Axonics initiated with a Buy at CL King
05/02/23 Needham
Axonics price target raised to $73 from $71 at Needham
04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
04/13/23 Mizuho
Axonics initiated with a Buy at Mizuho
AXNX Axonics
$51.58 /

+1.24 (+2.46%)

  • 03
    Aug
AXNX Axonics
$51.58 /

+1.24 (+2.46%)

Initiation
Axonics initiated with a Buy at CL King » 06:59
05/23/23
05/23
06:59
05/23/23
06:59
AXNX

Axonics

$51.58 /

+1.24 (+2.46%)

CL King analyst Kristen…

CL King analyst Kristen Stewart initiated coverage of Axonics with a Buy rating and $75 price target.

ShowHide Related Items >><<
AXNX Axonics
$51.58 /

+1.24 (+2.46%)

AXNX Axonics
$51.58 /

+1.24 (+2.46%)

05/02/23 Needham
Axonics price target raised to $73 from $71 at Needham
04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
04/13/23 Mizuho
Axonics initiated with a Buy at Mizuho
03/24/23 Needham
Needham upgrades Axonics to Buy on conservative guidance, attractive valuation
AXNX Axonics
$51.58 /

+1.24 (+2.46%)

  • 03
    Aug
AXNX Axonics
$51.58 /

+1.24 (+2.46%)

Over a week ago
Syndicate
Axonics files to sell common stock for holders, no amount given  06:11
05/05/23
05/05
06:11
05/05/23
06:11
AXNX

Axonics

$50.40 /

-1.34 (-2.59%)

 
ShowHide Related Items >><<
AXNX Axonics
$50.40 /

-1.34 (-2.59%)

AXNX Axonics
$50.40 /

-1.34 (-2.59%)

05/02/23 Needham
Axonics price target raised to $73 from $71 at Needham
04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
04/13/23 Mizuho
Axonics initiated with a Buy at Mizuho
03/24/23 Needham
Needham upgrades Axonics to Buy on conservative guidance, attractive valuation
AXNX Axonics
$50.40 /

-1.34 (-2.59%)

  • 03
    Aug
AXNX Axonics
$50.40 /

-1.34 (-2.59%)

Syndicate
Axonics files automatic mixed securities shelf  06:11
05/05/23
05/05
06:11
05/05/23
06:11
AXNX

Axonics

$50.40 /

-1.34 (-2.59%)

 
ShowHide Related Items >><<
AXNX Axonics
$50.40 /

-1.34 (-2.59%)

AXNX Axonics
$50.40 /

-1.34 (-2.59%)

05/02/23 Needham
Axonics price target raised to $73 from $71 at Needham
04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
04/13/23 Mizuho
Axonics initiated with a Buy at Mizuho
03/24/23 Needham
Needham upgrades Axonics to Buy on conservative guidance, attractive valuation
AXNX Axonics
$50.40 /

-1.34 (-2.59%)

  • 03
    Aug
AXNX Axonics
$50.40 /

-1.34 (-2.59%)

Recommendations
Axonics price target raised to $73 from $71 at Needham » 08:58
05/02/23
05/02
08:58
05/02/23
08:58
AXNX

Axonics

$58.65 /

+1.3 (+2.27%)

Needham analyst Mike…

Needham analyst Mike Matson raised the firm's price target on Axonics to $73 from $71 and keeps a Buy rating on the shares after its smaller than expected Q1 loss and Fy23 guidance raise. Axonics's F15 SNM system launched in April of 2022 and its new R20 SNM system launched in March, combined with direct-to-consumer ad campaign, were the key drivers of its strong revenue growth, the analyst tells investors in a research note.

ShowHide Related Items >><<
AXNX Axonics
$58.65 /

+1.3 (+2.27%)

AXNX Axonics
$58.65 /

+1.3 (+2.27%)

04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
04/13/23 Mizuho
Axonics initiated with a Buy at Mizuho
03/24/23 Needham
Needham upgrades Axonics to Buy on conservative guidance, attractive valuation
03/24/23 Needham
Axonics upgraded to Buy from Hold at Needham
AXNX Axonics
$58.65 /

+1.3 (+2.27%)

  • 03
    Aug
AXNX Axonics
$58.65 /

+1.3 (+2.27%)

On The Fly
Fly Intel: After-Hours Movers » 18:53
05/01/23
05/01
18:53
05/01/23
18:53
WWD

Woodward

$98.63 /

+2.56 (+2.66%)

, CLAR

Clarus

$9.51 /

-0.19 (-1.96%)

, SFM

Sprouts Farmers Market

$35.02 /

+0.34 (+0.98%)

, SIBN

SI-Bone

$22.57 /

+0.41 (+1.85%)

, TEX

Terex

$45.99 /

+1.31 (+2.93%)

, FLS

Flowserve

$33.94 /

+0.555 (+1.66%)

, ZI

ZoomInfo

$21.71 /

-0.22 (-1.00%)

, INST

Instructure

$26.67 /

+0.07 (+0.26%)

, KMT

Kennametal

$26.25 /

+0.29 (+1.12%)

, VNOM

Viper Energy

$29.13 /

-0.27 (-0.92%)

, ADUS

Addus HomeCare

$88.75 /

+7.2 (+8.83%)

, LSCC

Lattice Semiconductor

$81.61 /

+2.02 (+2.54%)

, STAG

STAG Industrial

$33.64 /

-0.21 (-0.62%)

, ETWO

E2open

$6.23 /

-0.05 (-0.80%)

, ANET

Arista Networks

$160.15 /

+0.17 (+0.11%)

, SYK

Stryker

$299.65 /

+0.03 (+0.01%)

, AXNX

Axonics

$58.65 /

+1.3 (+2.27%)

, FMC

FMC Corporation

$123.87 /

+0.31 (+0.25%)

, RMBS

Rambus

$45.29 /

+0.955 (+2.15%)

, VRTX

Vertex Pharmaceuticals

$344.87 /

+4.29 (+1.26%)

, SAVA

Cassava Sciences

$23.35 /

+0.13 (+0.56%)

, TVTX

Travere Therapeutics

$22.59 /

+1.03 (+4.78%)

Check out this evening's…

ShowHide Related Items >><<
ZI ZoomInfo
$21.71 /

-0.22 (-1.00%)

WWD Woodward
$98.63 /

+2.56 (+2.66%)

VRTX Vertex Pharmaceuticals
$344.87 /

+4.29 (+1.26%)

VNOM Viper Energy
$29.13 /

-0.27 (-0.92%)

TVTX Travere Therapeutics
$22.59 /

+1.03 (+4.78%)

TEX Terex
$45.99 /

+1.31 (+2.93%)

SYK Stryker
$299.65 /

+0.03 (+0.01%)

STAG STAG Industrial
$33.64 /

-0.21 (-0.62%)

SIBN SI-Bone
$22.57 /

+0.41 (+1.85%)

SFM Sprouts Farmers Market
$35.02 /

+0.34 (+0.98%)

SAVA Cassava Sciences
$23.35 /

+0.13 (+0.56%)

RMBS Rambus
$45.29 /

+0.955 (+2.15%)

KMT Kennametal
$26.25 /

+0.29 (+1.12%)

INST Instructure
$26.67 /

+0.07 (+0.26%)

FMC FMC Corporation
$123.87 /

+0.31 (+0.25%)

FLS Flowserve
$33.94 /

+0.555 (+1.66%)

ETWO E2open
$6.23 /

-0.05 (-0.80%)

CLAR Clarus
$9.51 /

-0.19 (-1.96%)

AXNX Axonics
$58.65 /

+1.3 (+2.27%)

ANET Arista Networks
$160.15 /

+0.17 (+0.11%)

ADUS Addus HomeCare
$88.75 /

+7.2 (+8.83%)

WWD Woodward
$98.63 /

+2.56 (+2.66%)

04/24/23 Truist
Woodward price target lowered to $85 from $93 at Truist
02/27/23 Credit Suisse
Woodward initiated with an Outperform at Credit Suisse
02/01/23 Alembic Global
Woodward upgraded to Overweight from Neutral at Alembic Global
01/31/23 Goldman Sachs
Woodward price target lowered to $74 from $76 at Goldman Sachs
CLAR Clarus
$9.51 /

-0.19 (-1.96%)

02/28/23 Lake Street
Clarus price target lowered to $20 from $22 at Lake Street
02/28/23 BofA
Clarus price target lowered to $10 from $12 at BofA
11/08/22 Lake Street
Clarus price target lowered to $22 from $35 at Lake Street
11/08/22 DA Davidson
Clarus downgraded to Neutral from Buy at DA Davidson
SFM Sprouts Farmers Market
$35.02 /

+0.34 (+0.98%)

04/20/23 Evercore ISI
Sprouts Farmers Market initiated with an Underperform at Evercore ISI
03/08/23 JPMorgan
Sprouts Farmers Market price target raised to $35 from $33 at JPMorgan
03/06/23 R5 Capital
Sprouts Farmers Market downgraded to Hold from Buy at R5 Capital
03/03/23 Deutsche Bank
Sprouts Farmers Market price target raised to $40 from $38 at Deutsche Bank
SIBN SI-Bone
$22.57 /

+0.41 (+1.85%)

02/28/23 Truist
SI-Bone price target raised to $26 from $21 at Truist
02/28/23 Needham
SI-Bone price target raised to $24 from $20 at Needham
02/28/23 Canaccord
SI-Bone price target raised to $24 from $21 at Canaccord
02/28/23 Cantor Fitzgerald
SI-Bone price target raised to $24 from $22 at Cantor Fitzgerald
TEX Terex
$45.99 /

+1.31 (+2.93%)

04/18/23 Citi
Terex price target lowered to $50 from $63 at Citi
04/12/23 Deutsche Bank
Terex price target raised to $53 from $51 at Deutsche Bank
03/17/23 BofA
Terex downgraded to Neutral from Buy at BofA
02/15/23 Citi
Terex downgraded to Neutral from Buy at Citi
FLS Flowserve
$33.94 /

+0.555 (+1.66%)

02/14/23 RBC Capital
Flowserve price target raised to $30 from $26 at RBC Capital
02/13/23 Baird
Flowserve price target raised to $42 from $32 at Baird
01/30/23 BofA
Flowserve upgraded to Buy at BofA on visibility and valuation
01/30/23 BofA
Flowserve upgraded to Buy from Neutral at BofA
ZI ZoomInfo
$21.71 /

-0.22 (-1.00%)

05/01/23 JPMorgan
ZoomInfo price target lowered to $31 from $34 at JPMorgan
02/07/23 Morgan Stanley
ZoomInfo price target lowered to $35 from $38 at Morgan Stanley
02/07/23 Wells Fargo
ZoomInfo price target lowered to $40 from $50 at Wells Fargo
02/07/23 Canaccord
ZoomInfo price target lowered to $35 from $43 at Canaccord
INST Instructure
$26.67 /

+0.07 (+0.26%)

12/15/22 Morgan Stanley
Chegg price target raised to $31 from $24 at Morgan Stanley
10/21/22 Citi
Instructure price target lowered to $27 from $30 at Citi
09/01/22 Citi
Instructure initiated with a Buy at Citi
05/03/22 Raymond James
Instructure price target lowered to $25 from $32 at Raymond James
KMT Kennametal
$26.25 /

+0.29 (+1.12%)

02/09/23 Loop Capital
Kennametal price target raised to $28 from $22 at Loop Capital
02/08/23 Barclays
Kennametal price target raised to $27 from $25 at Barclays
10/03/22 Barclays
Kennametal price target lowered to $24 from $25 at Barclays
08/03/22 Barclays
Kennametal price target lowered to $25 from $26 at Barclays
VNOM Viper Energy
$29.13 /

-0.27 (-0.92%)

04/20/23 Roth MKM
Roth MKM expects slight negative reaction to Blackstone Viper Energy stock sale
04/11/23 Truist
Viper Energy price target raised to $45 from $40 at Truist
03/30/23 Stifel
Viper Energy price target lowered to $33 from $35 at Stifel
03/07/23 Piper Sandler
Viper Energy price target lowered to $38 from $41 at Piper Sandler
ADUS Addus HomeCare
$88.75 /

+7.2 (+8.83%)

05/01/23 William Blair
Addus HomeCare dropped 30% on proposed CMS rule, says William Blair
04/28/23 RBC Capital
Addus HomeCare selloff 'overdone,' says RBC Capital
11/02/22 RBC Capital
Addus HomeCare price target raised to $121 from $110 at RBC Capital
08/03/22 Oppenheimer
Addus HomeCare price target lowered to $130 from $135 at Oppenheimer
LSCC Lattice Semiconductor
$81.61 /

+2.02 (+2.54%)

04/11/23 KeyBanc
Lattice Semiconductor price target raised to $110 from $100 at KeyBanc
02/22/23 Baird
Lattice Semiconductor price target raised to $100 from $75 at Baird
02/14/23 Rosenblatt
Lattice Semiconductor price target raised to $110 from $95 at Rosenblatt
02/14/23 Stifel
Lattice Semiconductor price target raised to $71 from $60 at Stifel
STAG STAG Industrial
$33.64 /

-0.21 (-0.62%)

02/06/23 BMO Capital
STAG Industrial initiated with an Outperform at BMO Capital
11/22/22 Wells Fargo
Wells Fargo downgrades STAG Industrial to Equal Weight, lowers target to $34
11/22/22 Wells Fargo
STAG Industrial downgraded to Equal Weight from Overweight at Wells Fargo
10/18/22 Wells Fargo
STAG Industrial price target lowered to $36 from $41 at Wells Fargo
ETWO E2open
$6.23 /

-0.05 (-0.80%)

01/10/23 UBS
E2open price target lowered to $6 from $7 at UBS
12/16/22 Redburn
E2open initiated with a Buy at Redburn
10/21/22 Goldman Sachs
E2open initiated with a Neutral at Goldman Sachs
09/23/22 Credit Suisse
E2open initiated with an Underperform at Credit Suisse
ANET Arista Networks
$160.15 /

+0.17 (+0.11%)

04/17/23 Evercore ISI
Arista Networks added to 'Tactical Outperform' list at Evercore ISI
04/14/23 Morgan Stanley
Arista Networks price target raised to $150 from $140 at Morgan Stanley
03/22/23 Wells Fargo
Arista Networks price target raised to $200 from $170 at Wells Fargo
03/15/23 Evercore ISI
Arista Networks can work to '$300+ levels' over time, says Evercore ISI
SYK Stryker
$299.65 /

+0.03 (+0.01%)

04/23/23 Bernstein
Stryker price target raised to $336 from $275 at Bernstein
04/17/23 Truist
Stryker price target raised to $300 from $275 at Truist
04/17/23 BTIG
Stryker price target raised to $299 from $281 at BTIG
04/17/23 Loop Capital
Stryker price target raised to $312 from $290 at Loop Capital
AXNX Axonics
$58.65 /

+1.3 (+2.27%)

04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
04/13/23 Mizuho
Axonics initiated with a Buy at Mizuho
03/24/23 Needham
Needham upgrades Axonics to Buy on conservative guidance, attractive valuation
03/24/23 Needham
Axonics upgraded to Buy from Hold at Needham
FMC FMC Corporation
$123.87 /

+0.31 (+0.25%)

04/21/23 Mizuho
FMC Corporation price target raised to $150 from $147 at Mizuho
03/17/23 Redburn
FMC Corporation upgraded to Buy from Neutral at Redburn
02/14/23 Goldman Sachs
FMC Corporation price target raised to $159 from $155 at Goldman Sachs
02/09/23 BMO Capital
FMC Corporation price target raised to $145 from $140 at BMO Capital
RMBS Rambus
$45.29 /

+0.955 (+2.15%)

04/24/23 Deutsche Bank
Rambus price target raised to $55 from $45 at Deutsche Bank
04/24/23 Susquehanna
Rambus weak server demand poses near-term risk, says Susquehanna
02/03/23 Susquehanna
Rambus price target raised to $60 from $36 at Susquehanna
01/30/23 Deutsche Bank
Rambus price target raised to $45 from $34 at Deutsche Bank
VRTX Vertex Pharmaceuticals
$344.87 /

+4.29 (+1.26%)

03/29/23 Raymond James
Bluebird Bio reaction to lovo-cel BLA delay 'overdone,' says Raymond James
03/29/23 Argus
Vertex Pharmaceuticals price target raised to $350 from $340 at Argus
03/21/23 Bernstein
Vertex Pharmaceuticals initiated with an Outperform at Bernstein
03/01/23 Guggenheim
Immunogen confident in early Elahere launch, says Guggenheim
SAVA Cassava Sciences
$23.35 /

+0.13 (+0.56%)

01/25/23 B. Riley
Cassava Sciences price target lowered to $28 from $44 at B. Riley
01/24/23 H.C. Wainwright
H.C. Wainwright positive on Cassava data, says buy the selloff
11/29/22 Univest Securities
Cassava Sciences price target lowered to $11 from $12 at Univest Securities
11/16/22 B. Riley
Cassava Sciences downgraded to Neutral at B. Riley amid limited disclosures
TVTX Travere Therapeutics
$22.59 /

+1.03 (+4.78%)

04/10/23 Guggenheim
Travere Therapeutics price target raised to $40 from $37 at Guggenheim
04/04/23 Barclays
Travere risk/reward positive into FSGS data, says Barclays
03/13/23 Piper Sandler
Travere Therapeutics price target lowered to $41 from $44 at Piper Sandler
02/28/23 Guggenheim
Travere Therapeutics initiated with a Buy, $37 price target at Guggenheim
ZI ZoomInfo
$21.71 /

-0.22 (-1.00%)

WWD Woodward
$98.63 /

+2.56 (+2.66%)

VRTX Vertex Pharmaceuticals
$344.87 /

+4.29 (+1.26%)

VNOM Viper Energy
$29.13 /

-0.27 (-0.92%)

TVTX Travere Therapeutics
$22.59 /

+1.03 (+4.78%)

TEX Terex
$45.99 /

+1.31 (+2.93%)

SYK Stryker
$299.65 /

+0.03 (+0.01%)

STAG STAG Industrial
$33.64 /

-0.21 (-0.62%)

SIBN SI-Bone
$22.57 /

+0.41 (+1.85%)

SFM Sprouts Farmers Market
$35.02 /

+0.34 (+0.98%)

SAVA Cassava Sciences
$23.35 /

+0.13 (+0.56%)

RMBS Rambus
$45.29 /

+0.955 (+2.15%)

LSCC Lattice Semiconductor
$81.61 /

+2.02 (+2.54%)

KMT Kennametal
$26.25 /

+0.29 (+1.12%)

INST Instructure
$26.67 /

+0.07 (+0.26%)

FMC FMC Corporation
$123.87 /

+0.31 (+0.25%)

FLS Flowserve
$33.94 /

+0.555 (+1.66%)

ETWO E2open
$6.23 /

-0.05 (-0.80%)

CLAR Clarus
$9.51 /

-0.19 (-1.96%)

AXNX Axonics
$58.65 /

+1.3 (+2.27%)

ANET Arista Networks
$160.15 /

+0.17 (+0.11%)

ADUS Addus HomeCare
$88.75 /

+7.2 (+8.83%)

  • 01
    Mar
  • 03
    Aug
VRTX Vertex Pharmaceuticals
$344.87 /

+4.29 (+1.26%)

SAVA Cassava Sciences
$23.35 /

+0.13 (+0.56%)

ANET Arista Networks
$160.15 /

+0.17 (+0.11%)

ZI ZoomInfo
$21.71 /

-0.22 (-1.00%)

VRTX Vertex Pharmaceuticals
$344.87 /

+4.29 (+1.26%)

TVTX Travere Therapeutics
$22.59 /

+1.03 (+4.78%)

TEX Terex
$45.99 /

+1.31 (+2.93%)

SYK Stryker
$299.65 /

+0.03 (+0.01%)

SFM Sprouts Farmers Market
$35.02 /

+0.34 (+0.98%)

SAVA Cassava Sciences
$23.35 /

+0.13 (+0.56%)

FMC FMC Corporation
$123.87 /

+0.31 (+0.25%)

FLS Flowserve
$33.94 /

+0.555 (+1.66%)

ETWO E2open
$6.23 /

-0.05 (-0.80%)

CLAR Clarus
$9.51 /

-0.19 (-1.96%)

AXNX Axonics
$58.65 /

+1.3 (+2.27%)

ANET Arista Networks
$160.15 /

+0.17 (+0.11%)

ZI ZoomInfo
$21.71 /

-0.22 (-1.00%)

VRTX Vertex Pharmaceuticals
$344.87 /

+4.29 (+1.26%)

SYK Stryker
$299.65 /

+0.03 (+0.01%)

SFM Sprouts Farmers Market
$35.02 /

+0.34 (+0.98%)

SAVA Cassava Sciences
$23.35 /

+0.13 (+0.56%)

RMBS Rambus
$45.29 /

+0.955 (+2.15%)

LSCC Lattice Semiconductor
$81.61 /

+2.02 (+2.54%)

ANET Arista Networks
$160.15 /

+0.17 (+0.11%)

Earnings
Axonics raises FY23 revenue view to $348M from $324M, consensus $347.8M  16:06
05/01/23
05/01
16:06
05/01/23
16:06
AXNX

Axonics

$58.82 /

+1.47 (+2.56%)

 
ShowHide Related Items >><<
AXNX Axonics
$58.82 /

+1.47 (+2.56%)

AXNX Axonics
$58.82 /

+1.47 (+2.56%)

04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
04/13/23 Mizuho
Axonics initiated with a Buy at Mizuho
03/24/23 Needham
Needham upgrades Axonics to Buy on conservative guidance, attractive valuation
03/24/23 Needham
Axonics upgraded to Buy from Hold at Needham
AXNX Axonics
$58.82 /

+1.47 (+2.56%)

  • 03
    Aug
AXNX Axonics
$58.82 /

+1.47 (+2.56%)

Earnings
Axonics reports Q1 EPS (19c), consensus (29c) » 16:05
05/01/23
05/01
16:05
05/01/23
16:05
AXNX

Axonics

$58.87 /

+1.52 (+2.65%)

Reports Q1 revenue…

Reports Q1 revenue $70.7M, consensus $65.3M. "Our commercial team continues to execute at a high level, generating revenue growth of 46% year over year in the first quarter," said Raymond W. Cohen, CEO. "Our sacral neuromodulation growth was driven by higher utilization and share gains while Bulkamid(R) continues to benefit from physicians enthusiastically adopting our durable hydrogel to treat their stress urinary incontinence patients. Based on the strong results generated in the first quarter, we are raising our fiscal year 2023 revenue guidance to $348 million, representing 27% growth year over year. We continue to focus on bringing new innovations to the incontinence market, with the goal of increasing the penetration of advanced therapies for this vastly undertreated patient population. In the first quarter, we received FDA approval and commercially launched the Axonics R20(TM), our fourth-generation rechargeable SNM system that requires recharging just once every six to ten months for one hour. In addition, last week we announced the acquisition of a technology to facilitate easier and faster lead placement during the SNM external trial. We are confident that this commitment to innovation, increasing public awareness, and providing physicians and patients strong clinical support will continue to drive market expansion and advance Axonics on its path to incontinence market leadership."

ShowHide Related Items >><<
AXNX Axonics
$58.87 /

+1.52 (+2.65%)

AXNX Axonics
$58.87 /

+1.52 (+2.65%)

04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
04/13/23 Mizuho
Axonics initiated with a Buy at Mizuho
03/24/23 Needham
Needham upgrades Axonics to Buy on conservative guidance, attractive valuation
03/24/23 Needham
Axonics upgraded to Buy from Hold at Needham
AXNX Axonics
$58.87 /

+1.52 (+2.65%)

  • 03
    Aug
AXNX Axonics
$58.87 /

+1.52 (+2.65%)

Over a month ago
Hot Stocks
Axonics acquired assets of Radian, terms not disclosed » 06:02
04/24/23
04/24
06:02
04/24/23
06:02
AXNX

Axonics

$60.29 /

+0.82 (+1.38%)

Axonics announced the…

Axonics announced the acquisition of a lead placement solution from Radian that complements Axonics' existing sacral neuromodulation offering. The technology has the potential to reduce procedure time and facilitate a more accurate placement which, in turn, can increase physicians' confidence in the SNM procedure and drive increased therapy adoption, utilization and permanent implant conversion rates. Axonics has acquired the assets of Radian from Intermed Labs for undisclosed terms. Axonics expects the product to receive FDA clearance and be available on a commercial basis in mid-2024.

ShowHide Related Items >><<
AXNX Axonics
$60.29 /

+0.82 (+1.38%)

AXNX Axonics
$60.29 /

+0.82 (+1.38%)

04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
04/13/23 Mizuho
Axonics initiated with a Buy at Mizuho
03/24/23 Needham
Needham upgrades Axonics to Buy on conservative guidance, attractive valuation
03/24/23 Needham
Axonics upgraded to Buy from Hold at Needham
AXNX Axonics
$60.29 /

+0.82 (+1.38%)

  • 03
    Aug
AXNX Axonics
$60.29 /

+0.82 (+1.38%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.